cloxyquin has been researched along with oxyquinoline in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Grunewald, GL; Kim, KH; Musto, JD; Sane, JN; Warner, VD | 1 |
| Borchardt, RT; Mirth, DB; Sane, JN; Thakker, DR; Warner, VD | 1 |
| Buabut, B; Hongmanee, P; Palittapongarnpim, P; Rukseree, K; Somsri, B | 1 |
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Byrd, MS; Campos, CG; Clare, M; Cotter, PA; Hagen, TJ; Henderson, MW; Horn, JR; Masoudi, A; Myler, PJ; Wangtrakuldee, P; Zhang, Z | 1 |
| Aoki, S; Ariyasu, S; Hanaya, K; Hoshi, M; Morita, A; Sawa, A; Takahashi, I; Wang, B | 1 |
| Campbell, Y; Cardellina, JH; Eccard, VS; Ensel, SM; Guernieri, R; Harrell, WA; Montgomery, V; Roxas-Duncan, V; Smith, LA; Vieira, RC; Webb, RP | 1 |
| Abendroth, J; Audia, JP; Chen, C; Edwards, TE; Hagen, TJ; Helgren, TR; Horn, JR; Housley, NA; Myler, PJ; Sankaran, B; Staker, BL; Wangtrakuldee, P | 1 |
| Dormán, G; Enyedy, ÉA; Palkó, R; Pape, VFS; Sessler, J; Soós, T; Szabó, MJ; Szakács, G; Szatmári, I; Tóth, S | 1 |
| Wojtowicz, EJ | 1 |
| BAYLES, A; ELSLAGER, EF; McCARTHY, DA; REINERTSON, JW; THOMPSON, PE | 1 |
| Cherdtrakulkiat, R; Lawung, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S; Sinthupoom, N; Tantimavanich, S; Worachartcheewan, A | 1 |
13 other study(ies) available for cloxyquin and oxyquinoline
| Article | Year |
|---|---|
Quantitative structure-activity relationships for 5-substituted 8-hydroxyquinolines as inhibitors of dental plaque.
Topics: Dental Plaque; Hydroxyquinolines; Oxyquinoline; Regression Analysis; Streptococcus mutans; Structure-Activity Relationship | 1977 |
Catechol O-methyltransferase. 8. Structure-activity relationships for inhibtion by 8-hydroxyquinolines.
Topics: Animals; Catechol O-Methyltransferase Inhibitors; Hydroxyquinolines; In Vitro Techniques; Liver; Male; Oxyquinoline; Rats; Regression Analysis; Structure-Activity Relationship | 1976 |
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Chloroquinolinols; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis, Pulmonary | 2007 |
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery of Inhibitors of
Topics: | 2013 |
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
Topics: Apoptosis; Cell Line, Tumor; Drug Design; Electrophoretic Mobility Shift Assay; Gamma Rays; Humans; Oxyquinoline; Radiation-Protective Agents; Tumor Suppressor Protein p53; Zinc | 2014 |
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.
Topics: Animals; Binding Sites; Botulinum Toxins, Type A; Hydroxyquinolines; Inhibitory Concentration 50; Mice; Phrenic Nerve; Protein Binding; Serogroup; Structure-Activity Relationship | 2017 |
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Methionyl Aminopeptidases; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pulmonary Artery; Rats; Rickettsia prowazekii; Structure-Activity Relationship | 2017 |
Structure-Activity Relationships of 8-Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer.
Topics: Antineoplastic Agents; Chelating Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mannich Bases; Neoplasms; Oxyquinoline; Structure-Activity Relationship | 2022 |
Reverse-phase high-performance liquid chromatographic determination of halogenated 8-hydroxyquinoline compounds in pharmaceuticals and bulk drugs.
Topics: Chloroquinolinols; Chromatography, High Pressure Liquid; Clioquinol; Hydroxyquinolines; Iodoquinol; Oxyquinoline | 1984 |
Antiamebic action of 5-chloro-7-diethylaminomethyl-8-quinolinol and of other substituted 8-quinolinols in vitro and in experimental animals.
Topics: Amebiasis; Animals; Chloroquinolinols; Dysentery, Amebic; Entamoeba histolytica; In Vitro Techniques; Oxyquinoline; Quinolines | 1955 |
Discovery of novel halogenated 8-hydroxyquinoline-based anti-MRSA agents: In vitro and QSAR studies.
Topics: Chloroquinolinols; Drug Design; Halogens; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Oxyquinoline; Quantitative Structure-Activity Relationship | 2020 |